|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 28/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 307K 287K 263K 493K 33.51M 505K 3.4M 1.33M 16.58M 1.31M 1.28M 57.32M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.22M 1.14M 1.04M 1.95M 133M 2M 13.48M 5.27M 65.67M 5.2M 5.09M 227M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 02/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/4/26 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 284K 265K 243K 455K 30.9M 466K 3.14M 1.23M 15.29M 1.21M 1.19M 52.87M | 350K 308K 287K 264K 494K 33.56M 506K 3.41M 1.33M 16.61M 1.32M 1.29M 57.41M |
| Net income | -685K -602K -562K -516K -966K -65.64M -989K -6.66M -2.61M -32.48M -2.57M -2.52M -112M | -9.09M -7.99M -7.46M -6.84M -12.81M -871M -13.12M -88.41M -34.58M -431M -34.13M -33.39M -1.49B |
| Net Debt | 1.27M 1.12M 1.04M 959K 1.79M 122M 1.84M 12.39M 4.84M 60.37M 4.78M 4.68M 209M | 1.04M 910K 849K 780K 1.46M 99.2M 1.5M 10.07M 3.94M 49.09M 3.89M 3.8M 170M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | USD 0.000001 | -.--% | 10,000 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















